Literature DB >> 17088184

Nasal grafts and implants in revision rhinoplasty.

Thomas Romo1, Edward S Kwak.   

Abstract

Problems associated with primary rhinoplasty are often due to overresection of the nasal skeleton. One of the primary goals in revision rhinoplasty is to restore nasal architecture. To do so, the facial plastic surgeon can choose from numerous grafting materials. A key understanding of the benefits and limitations of each implant or graft and implants commonly used in revision rhinoplasty surgery.

Mesh:

Substances:

Year:  2006        PMID: 17088184     DOI: 10.1016/j.fsc.2006.06.006

Source DB:  PubMed          Journal:  Facial Plast Surg Clin North Am        ISSN: 1064-7406            Impact factor:   1.918


  6 in total

1.  Stabilization of costal cartilage graft warping using infrared laser irradiation in a porcine model.

Authors:  Allen Foulad; Pedram Ghasri; Rohit Garg; Brian Wong
Journal:  Arch Facial Plast Surg       Date:  2010 Nov-Dec

2.  Laser surface modification of decellularized extracellular cartilage matrix for cartilage tissue engineering.

Authors:  Eva Goldberg-Bockhorn; Silke Schwarz; Rachana Subedi; Alexander Elsässer; Ricarda Riepl; Paul Walther; Ludwig Körber; Roman Breiter; Karl Stock; Nicole Rotter
Journal:  Lasers Med Sci       Date:  2017-12-06       Impact factor: 3.161

3.  Postrhinoplasty fibrotic syndrome.

Authors:  R P Gruber; M G Galvez; D D Ulvila
Journal:  HNO       Date:  2018-01       Impact factor: 1.284

4.  Problems associated with alloplastic materials in rhinoplasty.

Authors:  Hyun-Soo Kim; Su-Sung Park; Myung-Hoon Kim; Min-Su Kim; Seok-Kwun Kim; Keun-Cheol Lee
Journal:  Yonsei Med J       Date:  2014-11       Impact factor: 2.759

5.  Grafting in revision rhinoplasty.

Authors:  M Bussi; F Palonta; S Toma
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-06       Impact factor: 2.124

6.  Use of porous high-density polyethylene grafts in open rhinoplasty: no infectious complication seen in spreader and dorsal grafts.

Authors:  Shabahang Mohammadi; Mohammad Mohseni; Masoumeh Eslami; Hessein Arabzadeh; Morteza Eslami
Journal:  Head Face Med       Date:  2014-12-22       Impact factor: 2.151

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.